The Promensil Healthcare Professionals website is dedicated to providing health care professionals with clinical information regarding Promensil, so that you can confidently recommend Promensil to your patients or customers. You will find information on Promensil's efficacy, safety and tolerability profile, and clinical guidelines for Promensil, and there is the option to request clinical papers and product samples. If you are seeking further information, please contact Novogen. » Register to use this site » Have you forgotten your password? » Privacy statement Red Clover isoflavones are safe and well tolerated in women with a family history of breast cancer. This study * conducted by Trevor Powles of Parkside Oncology Unit, London, supports the growing body of evidence that treatment with red clover isoflavones is safe and well tolerated in healthy women. This 3 year, randomized, double blind, placebo controlled trial studied the effects of red clover isoflavones on women with at least one first degree relative with breast cancer. * Trevor J Powles, Anthony Howell, D Gareth Evans, Eugene V McCloskey, Sue Ashley, Rosemary Greenhalgh, Jenny Affen, Lesley Ann Flook and Alwynne Tidy. Red clover isoflavones are safe and well tolerated in women with a family history of breast cancer. Menopause International 2008; 14: 6-12. » Login above to find out more.

Login: Email Address: Password: Novogen Red Clover Promensil is available in the United Kingdom as Novogen Red Clover. The information in this global Promensil Healthcare Professionals website is also applicable to Novogen Red Clover. Please note: The content of the Promensil Healthcare Professionals website is intended for registered health care professionals only and not for use by the general public.